IBC Life Sciences has been the leading provider of conferences on microarray technologies, biomarkers and molecular diagnostics for many years and with great success. Drawing upon our 15th Annual Chips to Hits®, 7th Annual Biomarkers, and 7th annual Molecular Diagnostics meetings, we have developed the Discovery2Diagnostics Conference & Exhibition to reflect recent changes in these industries and to capture opportunities presented by the fast-paced developments in technologies and research throughout the discovery to diagnostics spectrum.
We have expanded the scope of this meeting to include more RNAi related research and development as it affects sequencing and detection technologies, biomarkers and molecular diagnostics, recent work to deliver point-of-care (or near POC) molecular diagnostics and sessions with panel discussions on related regulatory and reimbursement issues. The challenges experienced by those involved in the Discovery2Diagnostics spectrum and the enabling breakthroughs that bridge the gap between biomarkers and molecular diagnostics in the R&D setting and the clinic will also be explored.
| New Event Features - Scientific presentations on a range of diseases including: cancer, stroke, ALS, obesity, malaria, HPV, cardiovascular disease, cystic fibrosis, and more
- Just released MAQC-II September 2008 presentation and the latest ERCC activities
- Latest report from the Chair of The Secretary's Advisory Committee on Genetics, Health, and Society (SACGHS)
- Expanded coverage of hot topics in RNAi
- Interactive session on strategies for companion diagnostic development
- Informed viewpoints from industry insiders on the best approaches for biomarker and molecular diagnostic reimbursement
- Find out how novel proteomic analysis technologies are being used in biomarker discovery efforts
- Explore how Systems Biology informs biomarker discovery and validation in many settings
- New presentations on how functional genomics is being used to identify novel RNAi biomarkers
- Discover the new mass spectrometric approaches used to identify novel biomarkers from tissue samples
- Uncover how biomarker pipelines can be expanded by using massively parallel sequencing to identify functional genomic biomarkers
- Use the new online Partnering System: see who is attending, pre-schedule one-on-one meetings, develop relationships, and explore potential partners/collaborators
Exhibit Hall & Networking The exhibit hall will feature more than 50 companies offering products and services as well as over 80 poster presentations. You will enjoy an interactive and informative learning experience through the many high quality scientific session talks, poster presentations, high-level strategy forums, roundtable discussions, networking lunches and reception. This event is THE place to hear from and interact with world-renowned academics and industry thought leaders on topics and issues key to the development of sequencing and detection technologies, biomarkers, and molecular diagnostics. | Three Comprehensive and Interrelated Conference Tracks | 1 | Sequencing and Detection Technologies | - Learn about advances in miRNA prediction, detection, and analysis methods
- Explore Next Generation Sequencing technologies being used in novel applications
- Evaluate various miRNA purification and labeling methods for how they may impact downstream activity and analysis
| | 2 | Molecular Diagnostics | - Learn about companion diagnostics, third world diagnostics, commercialization of microarray-based molecular diagnostics for personalized medicine applications, and biomarker and molecular diagnostic reimbursement
- Hear viewpoints and updates on the regulatory environment important to molecular diagnostic development and success in the clinic
| | 3 | Biomarkers | - Gain scientific knowledge for development of effective patient stratification schema
- Hear about new research into miRNA, imaging, metabolomic, and proteomic biomarkers and how they inform diagnosis of a range of diseases
- Learn how functional RNAi molecules are being translated from markers into therapeutics
| |
View Keynote Presenters